First Drug Approved for Children with Rare Autoimmune Disorder

Abstract

Amifampridine (Ruzurgi) is the first drug approved for children ages six to 16 years with the rare autoimmune disorder Lambert–Eaton myasthenic syndrome. The drug can cause seizures and severe hypersensitivity.